Lung AI vs VX1+
AI Verdict
Choose Lung AI if…
Choose Lung AI if you require a portable, real-time diagnostic imaging solution for immediate assessment of cardiac and lung conditions at the point of care. This tool is ideal for emergency medicine, critical care, or pulmonology settings where rapid, on-site detection of issues like pleural effusion or consolidation is critical, even in environments without internet access. Its integrated AI and guided capture features also make it valuable for training and improving POCUS proficiency.
View Lung AI →Choose VX1+ if…
Choose VX1+ if your electrophysiology lab needs AI-powered assistance during cardiac ablation procedures for atrial fibrillation and tachycardia. This software is specifically designed to provide real-time identification of abnormal electrograms and dispersed electrograms (DEs), helping electrophysiologists pinpoint target areas for more effective ablation. It integrates seamlessly with existing EP recording and 3D mapping systems to enhance procedural guidance and outcomes.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Lung AI | VX1+ |
|---|---|---|
| Pricing | Unknown | Not publicly available |
| Deployment | Cloud-based, integrated with existing platforms (e.g., RapidAI), and potentially on-premise. | Software application on a computing platform, integrates with existing EP recording and 3D mapping systems. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Lung AITool A emphasizes ease of use with its handheld design, guided image capture, and dedicated education platform (Exo U), making advanced ultrasound more accessible for various users. Its on-device AI processing also allows it to operate without an internet connection, enhancing usability in diverse clinical settings. Tool B highlights a simple user interface and integration with existing systems, but Tool A's focus on democratizing POCUS with built-in guidance gives it an edge in overall usability.
Clinical Value
Lung AIBoth tools offer real-time AI assistance for critical clinical decisions and are FDA cleared. Tool A provides AI-powered detection for common and impactful conditions like pleural effusion, consolidation, and cardiac indicators, enabling real-time diagnostic decisions that can broadly improve patient outcomes. While Tool B offers specialized AI guidance for complex cardiac ablation procedures, Tool A's broader diagnostic applications for prevalent conditions likely offer wider clinical utility.
Pricing & Value
Lung AITool A provides publicly available pricing information, with the Exo Iris system starting at $3,500, and an essential package at $4,999 which includes a mandatory annual subscription of $1,200 after the first year. This transparency allows potential buyers to understand the initial and ongoing costs. Tool B's pricing is not publicly available, making it impossible to assess its value proposition without direct inquiry.
Enterprise Readiness
Lung AITool A explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are crucial for enterprise adoption. Its on-device AI processing also allows it to function without internet connectivity, enhancing its deployment flexibility in various healthcare environments. While Tool B integrates with existing EP systems, its HIPAA and BAA status are only 'expected' rather than explicitly stated, giving Tool A a clearer advantage in stated enterprise readiness.
Innovation
Lung AITool A pioneers a high-performance, handheld ultrasound platform with integrated AI, aiming to make affordable and easy-to-use medical imaging widely accessible. This approach of democratizing advanced diagnostics through miniaturization and on-device AI represents a significant innovation in healthcare delivery. Tool B's application of AI to guide complex cardiac ablation procedures is also innovative, but Tool A's broader impact on accessibility and deployment pushes the boundaries more significantly.
Support & Docs
Lung AITool A explicitly mentions 'Exo U,' an AI-powered POCUS education and training platform, indicating a commitment to user support and knowledge transfer. This dedicated educational resource helps users optimize their use of the device and its AI features. Tool B does not explicitly mention any specific support or documentation resources in the provided information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Lung AI | VX1+ |
|---|---|---|
| Product Name | Lung AI | VX1+ |
| Company | Exo | Volta Medical |
| Tagline | Handheld AI Ultrasound for Smarter Cardiac and Lung Scanning. | Transforming EP Data into AI Solutions |
| Primary Clinical Focus | High-performance, handheld ultrasound platform for imaging and therapeutic applications, focused on cardiac and lung scanning. | AI-powered software assisting electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Key AI Capabilities | AI-powered detection of pleural effusion; AI-powered detection of consolidation/atelectasis; Automated AI-based indicators for cardiac conditions; Real-time feedback and image quality monitoring (SweepAI); Guided image capture. | Real-time manual or automatic annotation of 3D anatomical and electrical maps; Identification of spatio-temporal dispersed electrograms (DEs); AI-driven insights to assist electrophysiologists. |
| Target Specialties | Cardiology, Emergency Medicine, Pulmonology | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring Lung AI and VX1+.